Synthesis and evaluation of novel HIV-1 enzyme inhibitors

dc.contributor.advisorKaye, Perry T
dc.contributor.advisorKlein, Rosalyn
dc.contributor.authorOlomola, Temitope Oloruntoba
dc.date.accessioned2026-03-04T11:09:11Z
dc.date.issued2011
dc.description.abstractThis study has involved the design, synthesis and evaluation of novel HIV-1 enzyme inhibitors accessed by synthetic elaboration of Baylis-Hillman adducts. Several series of complex coumarin-AZT and cinnamate ester-AZT conjugates have been prepared, in high yields, by exploiting the click reaction between appropriate Baylis-Hillman derived precursors and azidothymidine (AZT), all of which have been fully characterised using spectroscopic techniques. These conjugates, designed as potential dual-action HIV-1 inhibitors, were tested against the appropriate HIV-1 enzymes, i.e. HIV-1 reverse transcriptase and protease or HIV-1 reverse transcriptase and integrase. A number of the ligands have exhibited % inhibition levels and IC50 values comparable to drugs in clinical use, permitting their identification as lead compounds for the development of novel dual-action inhibitors. In silico docking of selected ligands into the active sites of the respective enzymes has provided useful insight into binding conformations and potential hydrogen-bonding interactions with active-site amino acid residues. A series of furocoumarin carboxamide derivatives have been synthesised in four steps starting from resorcinol and these compounds have also been tested for HIV-1 integrase inhibition activity. The structures of unexpected products isolated from Aza-Baylis-Hillman reactions of N-tosylaldimines have been elucidated by spectroscopic analysis, and confirmed by single crystal X-ray analysis. A mechanism for what appears to be an unprecedented transformation has been proposed. Microwave-assisted SeO₂ oxidation of Baylis-Hillman-derived 3-methylcoumarins has provided convenient and efficient access to coumarin-3-carbaldehydes, and a pilot study has revealed the potential of these coumarin-3-carbaldehydes as scaffolds for the construction of tricyclic compounds. The HCl-catalysed reaction of tert-butyl acrylate derived Baylis-Hillman adducts has been shown to afford 3-(chloromethyl)coumarins and α-(chloromethyl)cinnamic acids, the Zstereochemistry of the latter being established by X-ray crystallography. ¹H NMR-based experimental kinetic and DFT-level theoretical studies have been undertaken to establish the reaction sequence and other mechanistic details. Base-catalysed cyclisation on the other hand, has been shown to afford 2H-chromene rather than coumarin derivatives.
dc.description.degreeDoctoral thesis
dc.description.degreePhD
dc.format.extent256 pages
dc.format.mimetypeapplication/pdf
dc.identifier.otherhttp://hdl.handle.net/10962/d1005034
dc.identifier.urihttps://researchrepository.ru.ac.za/handle/123456789/6608
dc.languageEnglish
dc.publisherRhodes University, Faculty of Science, Department of Chemistry
dc.rightsOlomola, Temitope Oloruntoba
dc.subjectHIV infections -- Treatment
dc.subjectHIV infections -- Chemotherapy
dc.subjectHIV (Viruses)
dc.subjectEnzyme inhibitors
dc.subjectAZT (Drug)
dc.subjectReverse transcriptase
dc.subjectProteolytic enzymes
dc.subjectLigands
dc.subjectPsoralens
dc.subjectResorcinol
dc.titleSynthesis and evaluation of novel HIV-1 enzyme inhibitors
dc.typeAcademic thesis

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Synthesis_and_evaluation_of_novel_HIV-1_enzyme_inh_vital_4369.pdf
Size:
10.99 MB
Format:
Adobe Portable Document Format